Modification of natural hydrocolloid as disintegrant in aceclofenac tablet formulation
The purpose of present exploration was to modify kappa (k)-Carrageenan, by crosslinking, and assessed it as a tablet disintegrant to strengthen the solubility of the drug (aceclofenac) in tablet formulation. Modified k-Carrageenan was synthesized by reacting it with epichlorhydrin at heterogenous conditions. The swelling action of the product was investigated in order to optimize reaction circumstances for chemical cross-linking. Best modified k-Carrageenan procured by optimizing the reaction conditions and it was characterized for swelling index, particle size distribution, solubility, viscosity, gel strength and Fourier transform infrared spectroscopy (FTIR). Influence of modified k-Carrageenan on dissolution profile of therapeutic was also investigated along with other evaluation parameters. Modified k-Carrageenan exhibiting significant swelling index which is comparable to that of superdisintegrants. On comparative investigation as a tablet disintegrant by preparing anhydrous dicalcium phosphate tablet, modified k-Carrageenan showed disintegration time less than 20 seconds. Dissolution of aceclofenac (Class II) tablet formulaion utilizing modified k-Carrageenan was comparable with commercially available superdisintegrants. Faster dissolution of the accommodated drug was achieved with modified k-Carrageenan which was comparable with dissolution of the tablet formulation containing other superdisintegrants. The competent concentration of k-Carrageenan was found to be 5-15% as tablet disintegrant. Modified k-Carrageenan might be encouraging tablet disintegrant in fast dissolving formulations and can be worn in direct compression method.
Keywords: k-Carageenan. Epichlorhydrin. Aceclofenac. Crosslinking. Superdisintegrant
 Magliocca, S., De Caro, C., Lazzarato, L., Russo, R., Rolando, B., Chegaev, K., Cristiano, C. Aceclofenac–Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations. Molecular pharmaceutics 2018, 15, 3101-3110, https://doi.org/10.1021/acs.molpharmaceut.8b00195.
 Shaikh, R., O’Brien, D. P., Croker, D. M., & Walker, G. M. The development of a pharmaceutical oral solid dosage forms. In Computer Aided Chemical Engineering 2018, 41, 27-65, Elsevier.
 Madhulika, G. S. S. V., & Kuber, B. R. (2019). A review on natural and synthetic polymers employed in the formulation of oral disintegrating tablets. J Drug Deli Therapeutics 2019, 9, 652-658, https://doi.org/10.22270/jddt.v9i2-s.2553.
 Ruiz-Picazo, A., Lozoya-Agullo, I., González-Álvarez, I., Bermejo, M., & González-Álvarez, M. Effect of excipients on oral absorption process according to the different gastrointestinal segments. Expert Opin Drug Deliv 2020, https://doi.org/10.1080/17425247.2020.1813108.
 Singh, K., Goyal, L., Bawa, J., Kaur, S., Sharma, S., & Kumar, D. Fast dissolving tablets: An overview of preparation techniques and evaluation. The Pharma Inno J 2018, 7, 1090-1094.
 Acharya, P. C., Shetty, S., Fernandes, C., Suares, D., Maheshwari, R., & Tekade, R. K. Preformulation in Drug Research and Pharmaceutical Product Development. In Dosage Form Design Considerations 2018 (pp. 1-55). Academic Press.
 Arafat, B., Wojsz, M., Isreb, A., Forbes, R. T., Isreb, M., Ahmed, W., & Alhnan, M. A. Tablet fragmentation without a disintegrant: A novel design approach for accelerating disintegration and drug release from 3D printed cellulosic tablets. Eur J Pharm Sci 2018, 118, 191-199, https://doi.org/10.1016/j.ejps.2018.03.019.
 Khalil, H. P. S., Lai, T. K., Tye, Y. Y., Rizal, S., Chong, E. W. N., Yap, S. W., & Paridah, M. T. A review of extractions of seaweed hydrocolloids: Properties and applications. Express Polym Lett 2018, 12, 296-317, http://doi.org/10.3144/expresspolymlett.2018.27.
 Arufe, S., Torres, M. D., Chenlo, F., & Moreira, R. Air drying modelling of Mastocarpus stellatus seaweed a source of hybrid carrageenan. Heat Mass Tran 2018, 54, 177-184, https://doi.org/10.1007/s00231-017-2117-1.
 Layek, B., & Mandal, S. Natural polysaccharides for controlled delivery of oral therapeutics: a recent update. Carbohydr Polym 2020, 230, 115617, https://doi.org/10.1016/j.carbpol.2019.115617.
 Celebioglu, A., Topuz, F., & Uyar, T. Water-insoluble hydrophilic electrospun fibrous mat of cyclodextrin–epichlorohydrin polymer as highly effective sorbent. ACS Appl Polym Mater 2018, 1, 54-62, https://doi.org/10.1021/acsapm.8b00034.
 Li, L., Zhao, J., Sun, Y., Yu, F., & Ma, J. Ionically cross-linked sodium alginate/ĸ-carrageenan double-network gel beads with low-swelling, enhanced mechanical properties, and excellent adsorption performance. Chem Eng J 2019, 372, 1091-1103, https://www.x-mol.com/paperRedirect/5670002.
 Draksiene, G., Kopustinskiene, D. M., Lazauskas, R., & Bernatoniene, J. Psyllium (Plantago Ovata Forsk) Husk Powder as a natural superdisintegrant for orodispersible formulations: A study on meloxicam tablets. Molecules 2019, 24, 3255, https://doi.org/10.3390/molecules24183255.
 Yalçın, E., Uzun, A., & Çavuşoğlu, K. In vivo epiclorohidrine toxicity: cytogenetic, biochemical, physiological, and anatomical evidences. Environ Sci Pollut Res 2019, 26, 22400-22406, https://doi.org/10.1007/s11356-019-05518-y.
 Kumar, C. V., Vasa, P. K., Kumar, Y. R., Aparna, P., & Pratyusha, P. Enantiomeric Separation of S-Epichlorohydrin and R-Epichlorohydrin by Capillary Gas Chromatography with FID Detector. Am J Analyt Chem 2016, 7, 772-784, https://doi.org/10.4236/ajac.2016.711069 .
 Bhatti, S., & Kaushik, M. Utilization of natural superdisintegrant in mouth dissolving tablet: A simplified review. Tablet 2020, 8, 32-38.
 Pacheco-Quito, E. M., Ruiz-Caro, R., & Veiga, M. D. Carrageenan: Drug Delivery Systems and Other Biomedical Applications. Mar Drugs 2020, 18, 583, https://doi.org/10.3390/md18110583.
 Pudjiastuti, P., Wafiroh, S., Hendradi, E., Darmokoesoemo, H., Harsini, M., Fauzi, M. A. R. D., & Sarker, S. D. Disintegration, In vitro Dissolution, and Drug Release Kinetics Profiles of k-Carrageenan-based Nutraceutical Hard-shell Capsules Containing Salicylamide. Open Chem 2020, 18, 226-231, https://doi.org/10.1515/chem-2020-0028.
 Sahu, S. K., Banjare, T., Gupta, S., Bhandarkar, A., Sahu, H., Diwedi, S. D., & Sahu, K. Formulation and evaluation of orodispersible tablet of montelukast sodium. Res J Pharm Technol 2018, 11, 1112-1118, https://doi.org/10.5958/0974-360X.2018.00209.3.
 Qureshi, D., Nayak, S. K., Maji, S., Kim, D., Banerjee, I., & Pal, K. Carrageenan: a wonder polymer from marine algae for potential drug delivery applications. Curr Pharm Des 2019, 25, 1172-1186, https://doi.org/10.2174/1381612825666190425190754.
 Sharma V., Pathak K. Liquisolid system of paclitaxel using modified polysaccharides: In vitro cytotoxicity, apoptosis study, cell cycle analysis, in vitro mitochondrial membrane potential assessment, and pharmacokinetics. Int J Biol Macromol 2019, 137, 20-31, https://doi.org/10.1016/j.ijbiomac.2019.06.188
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).